HEALTH CANADA GRANTS CANNABIS CULTIVATION LICENCE TO BLISSCO
Blissco Cannabis Corp.'s (BLIS.C) wholly owned subsidiary, Bliss Co Holdings Ltd., has been granted a licence by Health Canada to cultivate cannabis plants and prepare dried cannabis.
"Earning our ACMPR licence to cultivate cannabis plants from Health Canada represents a significant milestone that the company has been working towards for four and a half years," said the company's chief executive officer and chair, Damian Kettlewell.
"Our ACMPR licence to cultivate allows us to execute on our strategic plan to build a distribution, brand and extraction focused cannabis company. We can now apply to expand our licence to include cannabis oil production. At the appropriate time we will apply for a licence to sell both dried cannabis and cannabis oil, from our own production and with premium dried cannabis sourced from our supply agreement. Considering our two-year supply agreement with the Supreme Cannabis Company Inc. for 3,000 kilograms of premium cannabis through June, 2020, Blissco is well positioned to generate revenue, subject to earning a licence to sell.
"We are grateful for the diligent and mindful work of our regulator and the steadfast support of our many industry partners and shareholders. Blissco is excited to build an iconic Canadian cannabis brand from our base in Vancouver, B.C."
About Blissco Cannabis Corp.
Blissco earned its Access to Cannabis for Medical Purposes Regulations (ACMPR) licence to cultivate on Thursday, March 29, 2018. Blissco's ACMPR facility in Langley, B.C., is designed to be a high-volume packager, processor and distributor of medical cannabis and adult-use cannabis when it is legal in Canada, which is currently anticipated to be by August, 2018, at the earliest. Blissco has a two-year supply agreement with the Supreme Cannabis Company Inc. to purchase premium dried cannabis curated over the last two years from imported cannabis seeds.